Paul R. Flynn's most recent trade in Dexcom Inc was a trade of 3,163 Common Stock done at an average price of $121.9 . Disclosure was reported to the exchange on Dec. 18, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DexCom | R. Flynn Paul | EVP Global Revenue | Sale or transfer of securities back to the company at price $ 121.85 per share. | 18 Dec 2023 | 3,163 | 48,949 (0%) | 0% | 121.9 | 385,412 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 17 Apr 2023 | 2,781 | 52,112 (0%) | 0% | 120 | 333,720 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 5,724 | 63,318 (0%) | 0% | 111.4 | 637,648 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 5,643 | 57,675 (0%) | 0% | 111.4 | 628,625 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 5,478 | 69,042 (0%) | 0% | 111.4 | 610,244 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale of securities on an exchange or to another person at price $ 106.27 per share. | 10 Mar 2023 | 2,782 | 54,893 (0%) | 0% | 106.3 | 295,643 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 18,776 | 74,520 (0%) | 0% | 0.0 | 19 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale of securities on an exchange or to another person at price $ 123.50 per share. | 08 Dec 2022 | 8,988 | 55,744 (0%) | 0% | 123.5 | 1,110,018 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 5,297 | 19,150 (0%) | 0% | 0.0 | 5 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 1,114 | 16,967 (0%) | 0% | 406.1 | 452,347 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 1,069 | 18,081 (0%) | 0% | 406.1 | 434,075 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 784 | 16,183 (0%) | 0% | 406.1 | 318,348 | Common Stock |
| DexCom | Paul R. Flynn | EVP, Global Revenue | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 2,925 | 13,853 (0%) | 0% | 0.0 | 3 | Common Stock |
| DexCom | Paul R. Flynn | EVP, Global Revenue | Sale of securities on an exchange or to another person at price $ 541.36 per share. | 09 Sep 2021 | 743 | 11,563 (0%) | 0% | 541.4 | 402,230 | Common Stock |
| DexCom | Paul R. Flynn | EVP, Global Revenue | Sale of securities on an exchange or to another person at price $ 558.33 per share. | 09 Sep 2021 | 626 | 10,928 (0%) | 0% | 558.3 | 349,515 | Common Stock |
| DexCom | Paul R. Flynn | EVP, Global Revenue | Sale of securities on an exchange or to another person at price $ 541.78 per share. | 09 Sep 2021 | 9 | 11,554 (0%) | 0% | 541.8 | 4,876 | Common Stock |
| DexCom | Paul R. Flynn | EVP, Global Revenue | Sale of securities on an exchange or to another person at price $ 400.00 per share. | 15 Apr 2021 | 758 | 12,306 (0%) | 0% | 400 | 303,200 | Common Stock |